Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life: ERRATUM
In the article on page 724 in volume 27, issue 8, there is an error in the Discussion section text. The second sentence in the fourth paragraph of the Discussion should read
“The incidence of fever of any intensity (rectal temperature ≥38.0°C/axillary temperature ≥37.5°C) was higher in the MMRV group during the 15 days after administration of the first dose, but most cases of fever reported during this study were high grade (rectal temperature ≥39.5°C/axillary temperature ≥39.0°C), with no statistically significant differences in the frequency of higher fever (>39.5°C) seen between groups after administration of either dose.” The text has been changed from “low grade” to “high grade” in the middle of the sentence.
1. Schuster V, Otto W, Maurer L, et al. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubellavaricella vaccine in healthy children during the second year of life. Pediatr Infect Dis J. 2008;27:724–730© 2013 Lippincott Williams & Wilkins, Inc.